BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27288630)

  • 21. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
    Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes of IL-2, IL-8, IL-10 and TNF-alpha levels in sera of patients with acute graft-versus-host disease].
    Wang SH; Da WM; Jin HJ; Jing Y; Yan GT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):755-8. PubMed ID: 16928315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Zhang X; Zhou Y; Xu L; Han W; Chen H; Chen Y; Fu H; Zhou S; Zhao J; Wang Q; Feng F; Zhu X; Liu K; Huang X
    Ann Hematol; 2015 May; 94(5):837-45. PubMed ID: 25512184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
    Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
    Front Immunol; 2021; 12():720354. PubMed ID: 34539656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study.
    Motaei J; Kerachian MA; Mousavi SA; Alimoghadam K; Ghavamzadeh A; Manoochehrabadi S; Ahmadvand M; Yaghmaie M
    Ann Hematol; 2021 Oct; 100(10):2621-2631. PubMed ID: 34247256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [SIRT1 deficiency in CD4+T cells induces acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Zhang Y; Yang J; Zhang G; Peng J; Chen X; Chen F; Xu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):697-703. PubMed ID: 30124203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease.
    Sakata N; Yasui M; Okamura T; Inoue M; Yumura-Yagi K; Kawa K
    Bone Marrow Transplant; 2001 Jun; 27(11):1153-61. PubMed ID: 11551026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between IL1B (+3954) polymorphisms and IL-1β levels in blood and saliva, together with acute graft-versus-host disease.
    Resende RG; Abreu MH; de Souza LN; Silva ME; Gomez RS; Correia-Silva Jde F
    J Interferon Cytokine Res; 2013 Jul; 33(7):392-7. PubMed ID: 23659674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation of the level of Reg3α protein in plasma with gastrointestinal acute graft-versus-host disease].
    Cai CS; Chen GH; Sun AN; Qiao M; Liu HW; Chen F; Wang Y; Qiu HY; Han Y; Ma X; Tang XW; Jin ZM; Fu CC; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):785-90. PubMed ID: 24989295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.
    Min SS; Mehra V; Clay J; Cross GF; Douiri A; Dew T; Basu TN; Potter V; Ceesay MM; Pagliuca A; Sherwood RA; Vincent RP
    J Clin Pathol; 2017 Oct; 70(10):886-890. PubMed ID: 28450387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.
    Rezvani AR; Storer BE; Storb RF; Mielcarek M; Maloney DG; Sandmaier BM; Martin PJ; McDonald GB
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1594-601. PubMed ID: 21806949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Medinger M; Heim D; Gerull S; Halter J; Krenger W; Buser A; Lengerke C; Bucher C; Passweg J
    Leuk Res; 2016 Aug; 47():22-5. PubMed ID: 27239737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The relationship between cytokine mRNA expression level and acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Zhao XS; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Aug; 31(8):545-50. PubMed ID: 21122335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
    Mohty M; Bagattini S; Chabannon C; Faucher C; Bardou VJ; Bilger K; Vey N; Gaugler B; Stoppa AM; Coso D; Ladaique P; Olive D; Viens P; Blaise D
    Exp Hematol; 2004 Nov; 32(11):1097-102. PubMed ID: 15539088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-181a and -b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses.
    Iravani Saadi M; Ramzi M; Hesami Z; Kheradmand N; Owjfard M; Nabi Abdolyousefi E; Karimi Z
    Virusdisease; 2021 Dec; 32(4):727-736. PubMed ID: 34722832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A panel of 4 biomarkers for the early diagnosis and therapeutic efficacy of aGVHD.
    Li X; Chen T; Gao Q; Zhang W; Xiao Y; Zhu W; Zeng L; Li Z; Yang S; Wang R; Wang X; Feng Y; Zhang X
    JCI Insight; 2019 Aug; 4(16):. PubMed ID: 31434801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.
    Pastore D; Delia M; Mestice A; Carluccio P; Perrone T; Gaudio F; Curci P; Rossi AR; Ricco A; Specchia G
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):887-93. PubMed ID: 22062803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.
    Ranganathan P; Ngankeu A; Zitzer NC; Leoncini P; Yu X; Casadei L; Challagundla K; Reichenbach DK; Garman S; Ruppert AS; Volinia S; Hofstetter J; Efebera YA; Devine SM; Blazar BR; Fabbri M; Garzon R
    J Immunol; 2017 Mar; 198(6):2500-2512. PubMed ID: 28159900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
    Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
    Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The correlated research of acute graft versus host disease after allogeneic stem cell transplantation].
    Yang F; Chen H; Liu GX; Lu M; Feng K; Zhang YG; Zhang J
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):264-8. PubMed ID: 16875562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.